- $31.18m
- $31.46m
- $27.04m
- 40
- 63
- 38
- 44
Annual balance sheet for DarioHealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 28.8 | 36 | 49.5 | 37.1 | 28.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.62 | 1.71 | 6.9 | 5.18 | 5.06 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 34.1 | 45.6 | 65.5 | 47.3 | 40.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.07 | 0.989 | 1.99 | 1.87 | 1.77 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 35.4 | 101 | 119 | 96.4 | 119 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.03 | 14.4 | 19.4 | 12.5 | 16.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 7.26 | 15.2 | 39.2 | 38.2 | 46.9 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 28.2 | 85.5 | 80 | 58.1 | 72 |
Total Liabilities & Shareholders' Equity | 35.4 | 101 | 119 | 96.4 | 119 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |